摘要:
sci-hub.st 参考文章(19)
J.C. Stoof, J. Booij, B. Drukarch, Amantadine as N-methyl-D-aspartic acid receptor antagonist: new possibilities for therapeutic applications? Clinical Neurology and Neurosurgery. ,vol. 94, pp. 4- 6 ,(1992) , 10.1016/0303-8467(92)90006-O
Levodopa and the progression of Parkinson's disease. The New England Journal of Medicine. ,vol. 351, pp. 2498- 2508 ,(2004) , 10.1056/NEJMOA033447
Effects of pergolide on nocturia in Parkinson's disease: three female cases selected from over 400 patients. Parkinsonism & Related Disorders. ,vol. 10, pp. 181- 187 ,(2004) , 10.1016/J.PARKRELDIS.2003.08.001
Andrew H Evans, Andrew J Lees, Dopamine dysregulation syndrome in Parkinson's disease. Current Opinion in Neurology. ,vol. 17, pp. 393- 398 ,(2004) , 10.1097/01.WCO.0000137528.23126.41
Heinz Reichmann, Michael H Brecht, J??rgen K??ster, Peter H Kraus, Mathias R Lemke, Pramipexole in routine clinical practice: a prospective observational trial in Parkinson's disease. CNS Drugs. ,vol. 17, pp. 965- 973 ,(2003) , 10.2165/00023210-200317130-00003
Kazutoshi Nishiyama, Toshimitsu Momose, Morihiro Sugishita, Manabu Sakuta, Positron emission tomography of reversible intellectual impairment induced by long-term anticholinergic therapy Journal of the Neurological Sciences. ,vol. 132, pp. 89- 92 ,(1995) , 10.1016/0022-510X(95)00131-K
Fabrizio Stocchi, Laura Vacca, Alfredo Berardelli, Marco Onofrj, Mario Manfredi, Stefano Ruggieri, Dual dopamine agonist treatment in Parkinson's disease. Journal of Neurology. ,vol. 250, pp. 822- 826 ,(2003) , 10.1007/S00415-003-1086-0
R. Horowski, K. P. Latt??, D. Palla, B. Schurad, C. Hofmann, U. Penner, R. Dorow, H. H. Pertz, S. J??hnichen, Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis. Clinical Neuropharmacology. ,vol. 29, pp. 80- 86 ,(2006) , 10.1097/00002826-200603000-00005
UK Rinne, F Bracco, C Chouza, E Dupont, O Gershanik, JF Marti Masso, JL Montastruc, CD Marsden, Early Treatment of Parkinson’s Disease with Cabergoline Delays the Onset of Motor Complications Drugs. ,vol. 55, pp. 23- 30 ,(1998) , 10.2165/00003495-199855001-00004
C. W. Olanow, V. V. Myllyla, K. A. Sotaniemi, J. P. Larsen, S. Palhagen, H. Przuntek, E. H. Heinonen, O. Kilkku, R. Lammintausta, O. Maki-Ikola, U. K. Rinne, Effect of selegiline on mortality in patients with Parkinson's disease: A meta-analysis Neurology. ,vol. 51, pp. 825- 830 ,(1998) , 10.1212/WNL.51.3.825